Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AWBT in CIU Patients
NCT07486583Phase 3Not yet recruiting
- Sponsor
- Cairo University
- Start
- Apr 2026
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 3, randomised trial in chronic idiopathic urticaria (CIU) (2 arms), sponsored by Cairo University. Primary endpoint: Urticaria Activity Score at 8 weeks. Planned start Apr 2026; status: not yet recruiting.
02
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on NCT07486583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07486583.